StockData
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. (NVCT) income statement

NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.39−0.45 (-2.27%)

Close on Nov 20, 2026Market cap $631.76MP/E –Yield 0.00%

See a number that looks wrong?